000163203 001__ 163203
000163203 005__ 20240229123151.0
000163203 0247_ $$2doi$$a10.2196/15167
000163203 0247_ $$2pmid$$apmid:32930673
000163203 0247_ $$2altmetric$$aaltmetric:90132948
000163203 037__ $$aDKFZ-2020-01900
000163203 041__ $$aeng
000163203 082__ $$a610
000163203 1001_ $$00000-0001-6662-2089$$aAmadou, Amina$$b0
000163203 245__ $$aChronic Low-Dose Exposure to Xenoestrogen Ambient Air Pollutants and Breast Cancer Risk: XENAIR Protocol for a Case-Control Study Nested Within the French E3N Cohort.
000163203 260__ $$aToronto$$c2020
000163203 3367_ $$2DRIVER$$aarticle
000163203 3367_ $$2DataCite$$aOutput Types/Journal article
000163203 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1600348181_8319
000163203 3367_ $$2BibTeX$$aARTICLE
000163203 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163203 3367_ $$00$$2EndNote$$aJournal Article
000163203 520__ $$aBreast cancer is the most frequent cancer in women in industrialized countries. Lifestyle and environmental factors, particularly endocrine-disrupting pollutants, have been suggested to play a role in breast cancer risk. Current epidemiological studies, although not fully consistent, suggest a positive association of breast cancer risk with exposure to several International Agency for Research on Cancer Group 1 air-pollutant carcinogens, such as particulate matter, polychlorinated biphenyls (PCB), dioxins, Benzo[a]pyrene (BaP), and cadmium. However, epidemiological studies remain scarce and inconsistent. It has been proposed that the menopausal status could modify the relationship between pollutants and breast cancer and that the association varies with hormone receptor status.The XENAIR project will investigate the association of breast cancer risk (overall and by hormone receptor status) with chronic exposure to selected air pollutants, including particulate matter, nitrogen dioxide (NO2), ozone (O3), BaP, dioxins, PCB-153, and cadmium.Our research is based on a case-control study nested within the French national E3N cohort of 5222 invasive breast cancer cases identified during follow-up from 1990 to 2011, and 5222 matched controls. A questionnaire was sent to all participants to collect their lifetime residential addresses and information on indoor pollution. We will assess these exposures using complementary models of land-use regression, atmospheric dispersion, and regional chemistry-transport (CHIMERE) models, via a Geographic Information System. Associations with breast cancer risk will be modeled using conditional logistic regression models. We will also study the impact of exposure on DNA methylation and interactions with genetic polymorphisms. Appropriate statistical methods, including Bayesian modeling, principal component analysis, and cluster analysis, will be used to assess the impact of multipollutant exposure. The fraction of breast cancer cases attributable to air pollution will be estimated.The XENAIR project will contribute to current knowledge on the health effects of air pollution and identify and understand environmental modifiable risk factors related to breast cancer risk.The results will provide relevant evidence to governments and policy-makers to improve effective public health prevention strategies on air pollution. The XENAIR dataset can be used in future efforts to study the effects of exposure to air pollution associated with other chronic conditions.DERR1-10.2196/15167.
000163203 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000163203 588__ $$aDataset connected to CrossRef, PubMed,
000163203 7001_ $$00000-0003-0339-3084$$aCoudon, Thomas$$b1
000163203 7001_ $$00000-0002-0857-7889$$aPraud, Delphine$$b2
000163203 7001_ $$00000-0001-5987-9839$$aSalizzoni, Pietro$$b3
000163203 7001_ $$00000-0002-1269-8069$$aLeffondre, Karen$$b4
000163203 7001_ $$00000-0001-6741-2518$$aLévêque, Emilie$$b5
000163203 7001_ $$00000-0002-5956-5693$$aBoutron-Ruault, Marie-Christine$$b6
000163203 7001_ $$00000-0002-6958-0109$$aDanjou, Aurélie M N$$b7
000163203 7001_ $$00000-0001-9877-6058$$aMorelli, Xavier$$b8
000163203 7001_ $$0P:(DE-He78)2d4cac0f4bf270325b98fe07036dc6c6$$aLe Cornet, Charlotte$$b9$$udkfz
000163203 7001_ $$00000-0003-4487-8723$$aPerrier, Lionel$$b10
000163203 7001_ $$00000-0003-4485-3489$$aCouvidat, Florian$$b11
000163203 7001_ $$00000-0003-2062-4681$$aBessagnet, Bertrand$$b12
000163203 7001_ $$00000-0001-8939-9369$$aCaudeville, Julien$$b13
000163203 7001_ $$00000-0003-3321-6679$$aFaure, Elodie$$b14
000163203 7001_ $$00000-0003-2297-3869$$aMancini, Francesca Romana$$b15
000163203 7001_ $$00000-0003-3423-2013$$aGulliver, John$$b16
000163203 7001_ $$00000-0001-7157-419X$$aSeveri, Gianluca$$b17
000163203 7001_ $$00000-0003-3498-6499$$aFervers, Béatrice$$b18
000163203 773__ $$0PERI:(DE-600)2719222-2$$a10.2196/15167$$gVol. 9, no. 9, p. e15167 -$$n9$$pe15167 $$tJMIR Research Protocols$$v9$$x1929-0748$$y2020
000163203 909CO $$ooai:inrepo02.dkfz.de:163203$$pVDB
000163203 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2d4cac0f4bf270325b98fe07036dc6c6$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000163203 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000163203 9141_ $$y2020
000163203 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2020-01-17
000163203 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-17
000163203 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-17
000163203 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000163203 980__ $$ajournal
000163203 980__ $$aVDB
000163203 980__ $$aI:(DE-He78)C020-20160331
000163203 980__ $$aUNRESTRICTED